Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
Investing.com - Zymeworks reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Zymeworks announced earnings per share of $-0.66 on revenue of $2.6M. Analysts polled by Investing.com EPS of $-0.89 on revenue of $5.55M.
Zymeworks 's are down 35% and is trading at $7.40 , still down 65.82% from its 52 week high of $22.32 set on Tuesday, November 9, 2021.
Zymeworks follows other major Healthcare sector earnings this month
Zymeworks's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar